INTENSITY THERAPEUTICS, INC. (INTS) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $0.00; Additional Paid in CapitalUSD $93.04M; Retained Earnings (Accumulated Deficit)USD $-83.83M.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $0.00; Additional Paid in CapitalUSD $90.80M; Retained Earnings (Accumulated Deficit)USD $-80.82M.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $0.00; Additional Paid in CapitalUSD $90.27M; Retained Earnings (Accumulated Deficit)USD $-78.39M.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $5.00K; Additional Paid in CapitalUSD $82.56M; Retained Earnings (Accumulated Deficit)USD $-75.34M.
INTENSITY THERAPEUTICS, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Warrant Issued USD | Retained Earnings, Appropriated USD |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $0.00 | $93.04M | $-83.83M | $9.21M | 3 month · $60.00K | 3 month · $387.00K | (m) | (m) |
| 2026-03-31 | $0.00 | $0.00 | $90.80M | $-80.82M | $9.98M | 3 month · $7.00K | 3 month · $387.00K | (m) | (m) |
| 2025-12-31 | $0.00 | $0.00 | $90.27M | $-78.39M | $11.88M | 12 month · $412.00K | 12 month · $2.00M | (m) | (m) |
| 2025-09-30 | $0.00 | $5.00K | $82.56M | $-75.34M | $7.22M | 3 month · $301.00K | 3 month · $471.00K | (m) | (m) |
| 2025-06-30 | $0.00 | $3.00K | $74.85M | $-72.67M | $2.18M | 3 month · $698.00K | 3 month · $644.00K | (m) | (m) |
| 2025-03-31 | $0.00 | $2.00K | $70.46M | $-70.13M | $334.00K | 3 month · $17.00K | 3 month · $435.00K | (m) | (m) |
| 2024-12-31 | $0.00 | $0.00 | $69.70M | $-66.78M | $2.92M | 12 month · $321.00K | 12 month · $3.07M | (m) | (m) |
| 2024-09-30 | $0.00 | $1.00K | $66.38M | $-63.60M | $2.78M | 3 month · $82.00K | 3 month · $483.00K | (m) | (m) |
| 2024-06-30 | $0.00 | $1.00K | $65.43M | $-60.09M | $5.34M | (m) | 3 month · $591.00K | (m) | (m) |
| 2024-03-31 | $0.00 | $1.00K | $64.84M | $-55.12M | $9.72M | (m) | 3 month · $1.16M | (m) | (m) |
| 2023-12-31 | $0.00 | $1.00K | $63.68M | $-50.52M | $13.16M | 12 month · $3.40M | 12 month · $1.40M | 12 month · $159.00K | (m) |
| 2023-09-30 | (m) | $1.37K | $63.25M | $-47.34M | $15.91M | (m) | 3 month · $351.00K | 9 month · $159.26K | $47.30M |
| 2023-06-30 | (m) | $1.31K | $58.82M | $-43.69M | $15.13M | (m) | 3 month · $312.00K | 6 month · $159.26K | $43.70M |
| 2023-03-31 | (m) | (m) | (m) | (m) | $-15.96M | (m) | 3 month · $312.00K | 3 month · $159.00K | (m) |
| 2022-12-31 | $0.00 | $0.00 | $23.55M | $-38.65M | $-15.10M | (m) | 12 month · $1.17M | (m) | (m) |
| 2022-09-30 | (m) | (m) | (m) | (m) | $-14.21M | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) | $-12.48M | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | (m) | (m) | (m) | $-10.78M | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | (m) | (m) | $-8.69M | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |